Form D · Other Technology
Neurophos Inc.
Austin, TX · CIK 0002119031
Offering snapshot reported Mar 16, 2026 · SEC filing
- Reported sold
- $109M Offering amount: $109M
- Investors reported
- 44 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2026 | Initial | $109,171,214 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576538
Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities.
Source: Form D, filed Mar 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Alliegro | Director |
| Patrick Bowen | Director, Executive |
| Hod Finkelstein | Executive |
| Nathan Kundtz | Director |
| Preston Woo | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4120 Freidrich Lane Suite 600
Austin, TX, 78744
Austin, TX, 78744